Nathan J. Schauer

1.1k total citations
10 papers, 407 citations indexed

About

Nathan J. Schauer is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nathan J. Schauer has authored 10 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nathan J. Schauer's work include Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Nathan J. Schauer is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Nathan J. Schauer collaborates with scholars based in United States and Germany. Nathan J. Schauer's co-authors include Sara J. Buhrlage, Xiaoxi Liu, Robert S. Magin, Laura M. Doherty, Wanyi Hu, Ellen Weisberg, Ilaria Lamberto, Roxana E. Iacob, Sirano Dhe‐Paganon and Kenneth C. Anderson and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Nathan J. Schauer

10 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan J. Schauer United States	6	364	183	64	43	38	10	407
Cécile Planquette Germany	4	482 1.3×	238 1.3×	71 1.1×	61 1.4×	29 0.8×	7	507
Susan Conrath Germany	2	468 1.3×	236 1.3×	70 1.1×	59 1.4×	27 0.7×	3	489
Oscar W. Huang United States	8	566 1.6×	144 0.8×	50 0.8×	66 1.5×	41 1.1×	8	614
Muthana Al Abo United States	10	365 1.0×	208 1.1×	32 0.5×	36 0.8×	42 1.1×	15	439
Adán Pinto-Fernández United Kingdom	13	371 1.0×	109 0.6×	73 1.1×	30 0.7×	95 2.5×	27	492
Ayşegül Sapmaz Netherlands	13	341 0.9×	119 0.7×	47 0.7×	22 0.5×	35 0.9×	28	421
Jenny Vu United States	5	330 0.9×	114 0.6×	41 0.6×	21 0.5×	45 1.2×	5	423
Sridhar Kavela India	6	340 0.9×	104 0.6×	25 0.4×	23 0.5×	27 0.7×	13	403
Alexander P. Boardman United States	5	355 1.0×	168 0.9×	47 0.7×	48 1.1×	33 0.9×	10	424

Countries citing papers authored by Nathan J. Schauer

Since Specialization

Citations

This map shows the geographic impact of Nathan J. Schauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan J. Schauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan J. Schauer more than expected).

Fields of papers citing papers by Nathan J. Schauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan J. Schauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan J. Schauer. The network helps show where Nathan J. Schauer may publish in the future.

Co-authorship network of co-authors of Nathan J. Schauer

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan J. Schauer. A scholar is included among the top collaborators of Nathan J. Schauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan J. Schauer. Nathan J. Schauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Liu, Xiaoxi, Robert S. Magin, Scott B. Ficarro, et al.. (2023). Accelerating inhibitor discovery for deubiquitinating enzymes. Nature Communications. 14(1). 686–686. 46 indexed citations

Rajasekaran, Karthik, Thomas J. Ow, Cherie‐Ann O. Nathan, et al.. (2023). Multiplexed trackable intratumor microdosing of the investigational STING agonist TAK-676 alone and in combination in the native tumor microenvironment of patients with head and neck cancer: A phase 0 trial.. Journal of Clinical Oncology. 41(16_suppl). 2579–2579. 2 indexed citations

Houlton, Jeffrey, Daniel Clayburgh, Ryan Li, et al.. (2022). 569 A CIVO intratumor microdose Phase 0 Trial of subasumstat (TAK-981) in combination with cetuximab or avelumab reveals Type 1 Interferon induction and immune activation in head and neck cancer patients. Regular and Young Investigator Award Abstracts. A596–A596. 3 indexed citations

Yang, Jing, Ellen Weisberg, Xiaoxi Liu, et al.. (2021). Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia. 36(1). 210–220. 19 indexed citations

Bushman, Jonathan W., Katherine A. Donovan, Nathan J. Schauer, et al.. (2020). Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors. Cell chemical biology. 28(1). 78–87.e3. 26 indexed citations

Schauer, Nathan J., Robert S. Magin, Xiaoxi Liu, Laura M. Doherty, & Sara J. Buhrlage. (2019). Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors. Journal of Medicinal Chemistry. 63(6). 2731–2750. 123 indexed citations

Stolte, Björn, Amanda Balboni Iniguez, Neekesh V. Dharia, et al.. (2018). Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma. The Journal of Experimental Medicine. 215(8). 2137–2155. 46 indexed citations

Lamberto, Ilaria, Xiaoxi Liu, Hyuk‐Soo Seo, et al.. (2017). Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7. Cell chemical biology. 24(12). 1490–1500.e11. 137 indexed citations

Buhrlage, Sara J., Ellen Weisberg, Nathan J. Schauer, et al.. (2016). Inhibition of USP10 Induces Degradation of Oncogenic FLT3: A Novel Approach to Therapy of Leukemia. Blood. 128(22). 524–524. 1 indexed citations

10.

Schroeder, Frederick A., et al.. (2014). First D₁-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring. American Journal of Physiology-Renal Physiology. 307(1). F116–F121. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact